Anumana Receives First and Only FDA Clearance for ECG-AI Cardiac Amyloidosis Algorithm Using a Standard 12-Lead ECG

US Northeast Healthcare Innovation Summit

Anumana is excited to bring our ground-breaking ECG-AI® technology to the US NE HIS event this year. Attending? Add the panel discussion featuring Anumana’s COO, Simos Kedikoglou, to your calendar!

Add to your Calendar
Date:
-
Address:
Location:
Share thie Event:

Clinically validated. Real-world performance.

4

FDA Breakthrough Device Designation

1

1 FDA Cleared ECG-AI algorithm

12+

Algorithms Under Development

3

Established Pharma Partnerships

75+

Peer Reviewed Publications on Neural Network of ECG-AI
Related Events